Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease ; volume:9 ; number:2 ; day:12 ; month:2 ; year:2018 ; pages:1-13 ; date:2.2018
Cell death & disease ; 9, Heft 2 (12.2.2018), 1-13, 2.2018
- Keyword
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Creator
-
Tozzi, Alessandro
- Contributor
-
Tantucci, Michela
Marchi, Saverio
Mazzocchetti, Petra
Morari, Michele
Pinton, Paolo
Mancini, Andrea
Calabresi, Paolo
SpringerLink (Online service)
- DOI
-
10.1038/s41419-017-0221-2
- URN
-
urn:nbn:de:1111-201804053789
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tozzi, Alessandro
- Tantucci, Michela
- Marchi, Saverio
- Mazzocchetti, Petra
- Morari, Michele
- Pinton, Paolo
- Mancini, Andrea
- Calabresi, Paolo
- SpringerLink (Online service)
Other Objects (12)
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Neuroprotection in Parkinson’s disease: facts and hopes
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Neuroprotection in Parkinson’s disease: facts and hopes
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
Pathogenic Mutation of Lrrk2 : A Mouse Model for pre-motor Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
Neuroprotection in Parkinson’s disease: facts and hopes
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis